AP1530A - Pharmaceutical composition for intramuscular injection containing loxoprofen. - Google Patents

Pharmaceutical composition for intramuscular injection containing loxoprofen.

Info

Publication number
AP1530A
AP1530A APAP/P/2002/002594A AP2002002594A AP1530A AP 1530 A AP1530 A AP 1530A AP 2002002594 A AP2002002594 A AP 2002002594A AP 1530 A AP1530 A AP 1530A
Authority
AP
ARIPO
Prior art keywords
intramuscular injection
pharmaceutical composition
injection containing
containing loxoprofen
loxoprofen
Prior art date
Application number
APAP/P/2002/002594A
Other versions
AP2002002594A0 (en
Inventor
Sung-Tae Lee
Shin Han
Woo-Yle Park
Chul-Kyu Lee
Hey-Sea Kim
Original Assignee
Shin Poong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co Ltd filed Critical Shin Poong Pharmaceutical Co Ltd
Publication of AP2002002594A0 publication Critical patent/AP2002002594A0/en
Application granted granted Critical
Publication of AP1530A publication Critical patent/AP1530A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a formulation for intramuscular injection containing loxoprofen or a pharmaceutically acceptable salt thereof, having an excellent anti-inflammatory analgesic effect, as an active ingredient.
APAP/P/2002/002594A 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen. AP1530A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0076298A KR100405161B1 (en) 2000-12-14 2000-12-14 Pharmaceutical composition for intramuscular injection containing loxoprofen
PCT/KR2001/002161 WO2002047661A1 (en) 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen

Publications (2)

Publication Number Publication Date
AP2002002594A0 AP2002002594A0 (en) 2002-09-30
AP1530A true AP1530A (en) 2006-01-04

Family

ID=36691545

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002594A AP1530A (en) 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen.

Country Status (12)

Country Link
JP (1) JP2004515526A (en)
KR (1) KR100405161B1 (en)
CN (1) CN1278672C (en)
AP (1) AP1530A (en)
AR (1) AR033596A1 (en)
AU (1) AU2002222750A1 (en)
BR (1) BR0108313A (en)
MX (1) MXPA02007788A (en)
OA (1) OA12175A (en)
RU (1) RU2232572C2 (en)
UA (1) UA76097C2 (en)
WO (1) WO2002047661A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
ES2528631T3 (en) 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Pharmaceutical formulations containing methylnaltrexone
TWI489984B (en) 2006-08-04 2015-07-01 Wyeth Corp Formulations for parenteral delivery of compounds and uses thereof
JP4456177B2 (en) 2007-09-04 2010-04-28 明治製菓株式会社 Injection, injection solution and injection kit preparation
EP2243477A1 (en) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol for parenteral application
JP2011225514A (en) * 2009-10-30 2011-11-10 Kowa Co Pharmaceutical composition containing loxoprofen or salt thereof
EP2926832A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen for topical use
EP2926810A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen
WO2015165847A1 (en) 2014-04-29 2015-11-05 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulations of loxoprofen
EP3160507A1 (en) 2014-06-30 2017-05-03 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and gamma-aminobutiric acid receptor agonist combinations
EP3197434A1 (en) 2014-09-24 2017-08-02 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740374A (en) * 1985-11-26 1988-04-26 Nitto Electric Industrial Co., Ltd. Anti-inflammatory analgesic adhesive preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161538A (en) * 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
JPH10120560A (en) * 1996-08-26 1998-05-12 Sankyo Co Ltd Topical formulation containing loxoprofen
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740374A (en) * 1985-11-26 1988-04-26 Nitto Electric Industrial Co., Ltd. Anti-inflammatory analgesic adhesive preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUGEMOTO ET AL.: 'Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-sodium, an anti-inflammatory prodrug' BIOCHEM. PHARMCOL. vol. 42, no. 12, 1991, pages 2363 - 2368 *

Also Published As

Publication number Publication date
KR20020046407A (en) 2002-06-21
RU2232572C2 (en) 2004-07-20
JP2004515526A (en) 2004-05-27
UA76097C2 (en) 2006-07-17
OA12175A (en) 2006-05-09
AP2002002594A0 (en) 2002-09-30
CN1400892A (en) 2003-03-05
AU2002222750A1 (en) 2002-06-24
CN1278672C (en) 2006-10-11
MXPA02007788A (en) 2002-10-17
AR033596A1 (en) 2003-12-26
KR100405161B1 (en) 2003-11-12
BR0108313A (en) 2003-03-11
WO2002047661A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001260414A1 (en) Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
TW200503685A (en) A pharmaceutical composition for inhibiting coronavirus
HRP20041211B1 (en) Topically applicable pharmaceutical preparation
WO2002015903A3 (en) Novel pharmaceutical composition for administering n-0923
UA84266C2 (en) Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyroolidon as excipient, processes for the preparation and use thereof
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
WO1999055332A8 (en) Medicinal compositions
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
BG66093B1 (en) Controlled release compositions comprising nimesulide
WO2002008217A3 (en) COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
AU3850600A (en) Dalda analogs and their use
DE60019334D1 (en) ANTIVIRAL ARZNEI
AP1530A (en) Pharmaceutical composition for intramuscular injection containing loxoprofen.
AP2003002763A0 (en) Controlled release formulations for oral administration
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
DK1383540T3 (en) Methods and pharmaceutical compositions for wound healing
SE0102440D0 (en) New compound
WO2005117895A8 (en) Compositions comprising meloxicam
SE9900070D0 (en) New use
EP1169320A4 (en) Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
CA2402707A1 (en) Use of cdp-choline for the treatment of alcohol withdrawal syndrome
BR0001144B1 (en) PHARMACEUTICAL COMPOSITION OF VITAMIN-E, PAPAINE AND HYALURONIDASE-BASED DICLOPHENAC
CA2499620A1 (en) External preparation containing acetylsalicylic acid for inhibiting keloid formation